101: Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen

101: Biotechnology and Healthcare: A New Dawn...

Up next

200: Is the 60/40 Portfolio Still Fit for Purpose? State Street Investment Management’s CEO, Yie Hsin Hung, Discusses Flows, Valuations, EM, Private Equity Returns and Tokenisation, the Next Investment Frontier

We were surprised, when researching for this interview, to learn that State Street Investment Management are the fourth largest asset manager globally, with circa $6 Trillion of assets. Size confers both opportunity and challenges, however, and in this conversation Yie-Hsin talks ...  Show more

199: Can A.I. Improve Investment Results? With Rob Arnott, Founder & Chair of Research Affiliates.

Rob Arnott, Founder & Chair of Research Affiliates, discusses where AI works well & can assist across the money management ecosystem, the risk of ‘AI hallucination’ & over-reliance, quant vs human judgement, and the future of work. Amidst the volumes written about AI’s impact on ...  Show more

Recommended Episodes

Human Health: Society and the Future of Biotech
The Next Five

Biotechnology is the use of biology in the production of new products, services, and organisms with the aim of improving human health and society. In 2024, the global biotech market was worth $1.68 trillion. By application, the health segment was responsible for just over half of ...  Show more

Billionaire Naveen Jain Reveals How AI Will Change Medicine Forever | EP #121
Moonshots with Peter Diamandis

In this episode, Peter and Naveen discuss the future of healthcare, how AI will revolutionize our health, and how to raise Moonshot kids.    Recorded on July 22nd, 2024 Views are my own thoughts, not Financial, Medical, or Legal Advice. 05:04 | The Cost of Chronic Diseases 38 ...  Show more

Ray Dalio on AI, Job Loss & the Future of the Economy | #EP 148
Moonshots with Peter Diamandis

In this episode, Ray and Peter discuss the changing world order, China vs. the USA, and Ray’s thoughts on the future of the US. Recorded on Feb 3rd, 2025 Views are my own thoughts; not Financial, Medical, or Legal Advice. Ray Dalio is a renowned investor, hedge fund manager, an ...  Show more

Kate Cronin (Moderna) | Pioneering Biotech Company and their Software of Life
The CMO Podcast

Fall means it's time for your annual flu and Covid shots! So, this week on The CMO Podcast, Jim welcomes Kate Cronin, the Chief Brand Officer for Moderna, the 14-year-old pioneering biotech company. Moderna achieved nearly instant awareness and fame in 2020, when it received ...

  Show more